We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-16.4%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
AUM
$153M
AUM Growth
-$5.06M
Cap. Flow
+$34.5M
Cap. Flow %
22.6%
Top 10 Hldgs %
55.32%
Holding
88
New
19
Increased
22
Reduced
12
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 30.69%
2 Technology 14.56%
3 Communication Services 8.94%
4 Financials 6.48%
5 Consumer Discretionary 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$1.96M 1.28%
17,000
XLNX
27
DELISTED
Xilinx Inc
XLNX
$1.95M 1.28%
25,000
+9,250
+59% +$806K
AOD
28
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$1.91M 1.25%
289,917
+8,500
+3% +$69.6K
CSCO icon
29
Cisco
CSCO
$457B
$1.28M 0.84%
+32,500
New +$1.43M
XYZ
30
Block Inc
XYZ
$48.4B
$1.05M 0.69%
20,000
+15,000
+300% +$1.03M
GDXJ icon
31
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$984K 0.64%
+35,000
New +$1.33M
LOW icon
32
Lowe's Companies
LOW
$117B
$947K 0.62%
+11,000
New +$1.2M
IBM icon
33
IBM
IBM
$211B
$832K 0.54%
+7,845
New +$992K
AMRN
34
Amarin Corp
AMRN
$298M
$816K 0.53%
10,200
+2,700
+36% +$897K
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
$808K 0.53%
+9,000
New +$883K
NKTR icon
36
Nektar Therapeutics
NKTR
$2.39B
$768K 0.5%
2,867
GEN icon
37
Gen Digital
GEN
$16.4B
$748K 0.49%
40,000
HYG icon
38
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$732K 0.48%
+9,500
New +$803K
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
$709K 0.46%
+15,500
New +$787K
ESPR
40
DELISTED
Esperion Therapeutics
ESPR
$694K 0.45%
22,000
+7,000
+47% +$369K
ARNA
41
DELISTED
Arena Pharmaceuticals Inc
ARNA
$693K 0.45%
+16,500
New +$757K
AAPL icon
42
Apple
AAPL
$4.54T
$636K 0.42%
10,000
GM icon
43
General Motors
GM
$80.4B
$623K 0.41%
+30,000
New +$916K
APTV icon
44
Aptiv
APTV
$12B
$616K 0.4%
12,500
+7,500
+150% +$588K
BOX icon
45
Box
BOX
$4.37B
$562K 0.37%
40,000
+5,000
+14% +$74.4K
INTC icon
46
Intel
INTC
$455B
$541K 0.35%
10,000
STEW
47
SRH Total Return Fund
STEW
$1.79B
$541K 0.35%
58,783
KYNB
48
Kyntra Bio
KYNB
$27.2M
$469K 0.31%
540
-160
-23% -$159K
NOK icon
49
Nokia
NOK
$51B
$465K 0.3%
150,000
JPM icon
50
JPMorgan Chase
JPM
$935B
$450K 0.29%
+5,000
New +$607K

Similar funds

DCF Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, DCF Advisers held 88 positions worth $153M, down 3.2% from $158M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

DCF Advisers deployed $34.5M of net new capital in Q1 2020, opening 19 new positions and adding to 22 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 15,000 shares worth $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $1.27M trimmed.

  • DCF Advisers's largest Q1 2020 buy was Berkshire Hathaway Class B: 15,000 shares worth $2.74M.
  • DCF Advisers added most to Verizon in Q1 2020, an estimated $1.43M increase.
  • DCF Advisers's biggest Q1 2020 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.27M.
  • DCF Advisers fully exited Home Depot in Q1 2020, selling an estimated $2.18M.
  • DCF Advisers's ten largest holdings make up 55% of its $153M portfolio in Q1 2020.
  • DCF Advisers opened 19 new positions and closed 21 in Q1 2020.
  • DCF Advisers's portfolio value fell 3.2% quarter-over-quarter to $153M.

Based on DCF Advisers's 13F filing for Q1 2020, filed 12 May 2020.